Liver Research, 2021 Patients with recurrent hepatocellular carcinoma (HCC) following liver transplantation (LT) have a poor prognosis owing to rapid tumor progression.
Jian-Wen Zhang +6 more
doaj +1 more source
Contrast-enhanced Ultrasound Assessment of Treatment Response in a Patient with Multifocal Hepatocellular Carcinoma Treated with Transarterial Chemo and Radioembolization [PDF]
Advanced Ultrasound in Diagnosis and Therapy, 2021 Minimally invasive locoregional therapies have become important treatment options for patients with intermediate or late-stage hepatocellular carcinoma (HCC) who are ineligible for surgical resection or liver transplantation.
Esika Savsani, Mohamed Tantawi, MD, Corinne E. Wessner, MBA, RDMS, RVT, Philip Lee, MD, Andrej Lyshchik, MD, PhD, Kevin Anton, MD, PhD, Colette M. Shaw, MD, Ji-Bin Liu, MD, John R. Eisenbrey, PhD
doaj +1 more source
Reappraisal of transarterial radioembolization for liver-confined hepatocellular carcinoma with portal vein tumor thrombosis: Editorial on "Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis". [PDF]
Clin Mol HepatolKim JH, Kim GH, Gwon DI.
europepmc +3 more sources
The Objective Response and Disease Control Rates in Patients with Liver Metastastic Breast Cancer Receiving Transarterial Radioembolization: A Meta-Analysis. [PDF]
Curr OncolQuartuccio N +6 more
europepmc +3 more sources
PLoS ONE, 2021 BackgroundRecently, the use of Yttrium-90 transarterial radioembolization in non-surgical hepatocellular carcinoma was suggested but the evidence supporting its use is unclear.MethodsWe searched Medline, Embase, Web of Science and Cochrane CENTRAL from ...
Simon Lemieux +6 more
doaj +1 more source
The Arab Journal of Interventional Radiology, 2023 Background Prophylactic cystic artery embolization (CAE) is used to prevent radiation cholecystitis in patients undergoing transarterial radioembolization (TARE), but the incidence of ischemic cholecystitis following CAE remains unclear.
Benjamin J. Walker +5 more
doaj +1 more source
Transarterial radioembolization for liver tumors as neoadjuvant therapy: three case reports
Einstein (São Paulo), 2020 Transarterial radioembolization (TARE) with yttrium-90 microspheres is a palliative locoregional treatment, minimally invasive for liver tumors. The neoadjuvant aim of this treatment is still controversial, however, selected cases with lesions initially ...
Vithor de Oliveira Carvalho +9 more
doaj +2 more sources
Transarterial Radioembolization for Management of Hepatocellular Carcinoma. [PDF]
Oncologist, 2023 Abstract Transarterial radioembolization (TARE) with Yttrium-90 (Y90) is a growing area of study due to its benefits in early-, intermediate-, and late-stage hepatocellular carcinoma. Treatment intent, including curative therapy, bridging to transplant, and downstaging disease, informs treatment approach and dosimetry goals.
Badar W, Yu Q, Patel M, Ahmed O.
europepmc +3 more sources
Standards of Practice in Transarterial Radioembolization [PDF]
CardioVascular and Interventional Radiology, 2013 Complications (minor/major) A minor complication is a treatment-related adverse event requiring no or minimal therapy with or without overnight hospitalization for observation. A major complication is a treatment-related adverse event requiring further therapy, increased level of care, or prolonged hospitalization [11].
Andreas H, Mahnken +4 more
openaire +2 more sources
Transarterial RAdioembolization versus ChemoEmbolization for the treatment of hepatocellular carcinoma (TRACE) : study protocol for a randomized controlled trial [PDF]
, 2012 Background: Hepatocellular carcinoma is a primary malignant tumor of the liver that accounts for an important health problem worldwide. Only 10 to 15% of hepatocellular carcinoma patients are suitable candidates for treatment with curative intent, such ...
Al Younis, Imad +11 more
core +1 more source